诊断学理论与实践››2017,Vol. 16››Issue (06): 659-663.doi:10.16150/j.1671-2870.2017.06.019
陈媛媛1,2, 王燕萍2, 吴丽苹2, 陈亚芬2, 杨克2, 刘艳1,2
收稿日期:2017-06-20出版日期:2017-12-25发布日期:2017-12-25通讯作者:刘艳 E-mail: liuyan_ivy@126.com基金资助:
Received:2017-06-20Online:2017-12-25Published:2017-12-25中图分类号:
陈媛媛, 王燕萍, 吴丽苹, 陈亚芬, 杨克, 刘艳. 卵泡抑素样蛋白1及其在心血管疾病中的作用研究进展[J]. 诊断学理论与实践, 2017, 16(06): 659-663.
| [1] Chaly Y, Hostager B, Smith S, et al.Follistatin-like protein 1 and its role in inflammation and inflammatory di-seases[J]. Immunol Res,2014,59(1-3):266-272. [2] Hambrock HO, Kaufmann B, Müller S, et al.Structural characterization of TSC-36/Flik: analysis of two charge isoforms[J]. J Biol Chem,2004,279(12):11727-11735. [3] Sundaram GM, Common JE, Gopal FE, et al.'See-saw' expression of microRNA-198 and FSTL1 from a single transcript in wound healing[J]. Nature,2013,495(7439):103-106. [4] Zwijsen A, Blockx H, van Arnhem W, et al. Characterization of a rat C6 glioma-secreted follistatin-related protein(FRP). Cloning and sequence of the human homologue[J]. Eur J Biochem,1994,225(3):937-946. [5] Shibanuma M, Mashimo J, Mita A, et al.Cloning from a mouse osteoblastic cell line of a set of transforming-growth-factor-beta 1-regulated genes, one of which seems to encode a follistatin-related polypeptide[J]. Eur J Biochem,1993,217(1):13-19. [6] Wei K, Serpooshan V, Hurtado C, et al.Epicardial FSTL1 reconstitution regenerates the adult mammalian heart[J]. Nature,2015,525(7570):479-485. [7] Maruyama S, Nakamura K, Papanicolaou KN, et al.Follistatin-like 1 promotes cardiac fibroblast activation and protects the heart from rupture[J]. EMBO Mol Med,2016,8(8):949-966. [8] Chan QK, Ngan HY, Ip PP, et al.Tumor suppressor effect of follistatin-like 1 in ovarian and endometrial carcinogenesis: a differential expression and functional analysis[J]. Carcinogenesis,2009,30(1):114-121. [9] Sumitomo K, Kurisaki A, Yamakawa N, et al.Expression of a TGF-beta1 inducible gene, TSC-36, causes growth inhibition in human lung cancer cell lines[J]. Cancer Lett,2000,155(1):37-46. [10] Liu S, Wang L, Wang W, et al.TSC-36/FRP inhibits vascular smooth muscle cell proliferation and migration[J]. Exp Mol Pathol,2006,80(2):132-140. [11] Zhou X, Xiao X, Huang T, et al.Epigenetic inactivation of follistatin-like 1 mediates tumor immune evasion in nasopharyngeal carcinoma[J]. Oncotarget,2016,7(13):16433-16444. [12] Shimano M, Ouchi N, Nakamura K, et al.Cardiac myo-cyte follistatin-like 1 functions to attenuate hypertrophy following pressure overload[J]. Proc Natl Acad Sci U S A,2011,108(43):E899-E906. [13] Ogura Y, Ouchi N, Ohashi K, et al.Therapeutic impact of follistatin-like 1 on myocardial ischemic injury in preclinical models[J]. Circulation,2012,126(14):1728-1738. [14] Murakami K, Tanaka M, Usui T, et al.Follistatin-related protein/follistatin-like 1 evokes an innate immune response [15] Tanaka M, Murakami K, Ozaki S, et al.DIP2 disco-interacting protein 2 homolog A (Drosophila) is a candidate receptor for follistatin-related protein/follistatin-like 1--analysis of their binding with TGF-β superfamily proteins[J]. FEBS J,2010,277(20):4278-4289. [16] Ouchi N, Asaumi Y, Ohashi K, et al.DIP2A functions as a FSTL1 receptor[J]. J Biol Chem,2010,285(10):7127-7134. [17] Tanaka M, Ozaki S, Kawabata D, et al.Potential preventive effects of follistatin-related protein/TSC-36 on joint destruction and antagonistic modulation of its autoantibodies in rheumatoid arthritis[J]. Int Immunol,2003,15(1):71-77. [18] Ouchi N, Oshima Y, Ohashi K, et al.Follistatin-like 1, a secreted muscle protein, promotes endothelial cell function and revascularization in ischemic tissue through a nitric-oxide synthase-dependent mechanism[J]. J Biol Chem,2008,283(47):32802-32811. [19] Oshima Y, Ouchi N, Sato K, et al.Follistatin-like 1 is an Akt-regulated cardioprotective factor that is secreted by the heart[J]. Circulation,2008,117(24):3099-3108. [20] Liu S, Shen H, Xu M, et al.FRP inhibits ox-LDL-induced endothelial cell apoptosis through an Akt-NF-{kappa}B-Bcl-2 pathway and inhibits endothelial cell apoptosis in an apoE-knockout mouse model[J]. Am J Physiol Endocrinol Metab,2010,299(3):E351-E363. [21] Pachori AS, Custer L, Hansen D, et al.Bone morphogenetic protein 4 mediates myocardial ischemic injury through JNK-dependent signaling pathway[J]. J Mol Cell Cardiol,2010,48(6):1255-1265. [22] Wu X, Li H, Kang L, et al.Activated matrix metalloproteinase-2--a potential marker of prognosis for epithelial ovarian cancer[J]. Gynecol Oncol,2002,84(1):126-134. [23] Leroy-Dudal J, Demeilliers C, Gallet O, et al.Transmigration of human ovarian adenocarcinoma cells through endothelial extracellular matrix involves alphav integrins and the participation of MMP2[J]. Int J Cancer,2005, 114(4):531-543. [24] Monge M, Colas E, Doll A, et al.ERM/ETV5 up-regulation plays a role during myometrial infiltration through matrix metalloproteinase-2 activation in endometrial cancer[J]. Cancer Res,2007,67(14):6753-6759. [25] Watakabe A, Komatsu Y, Nawa H, et al.Gene expression profiling of primate neocortex: molecular neuroanatomy of cortical areas[J]. Genes Brain Behav,2006,5(Suppl 1):38-43. [26] Li KC, Wang F, Zhong YQ, et al.Reduction of follistatin-like 1 in primary afferent neurons contributes to neuropathic pain hypersensitivity[J]. Cell Res,2011,21(4):697-699. [27] Lara-Pezzi E, Felkin LE, Birks EJ, et. Expression of follistatin-related genes is altered in heart failure[J]. Endocrinology,2008,149(11):5822-5827. [28] Widera C, Horn-Wichmann R, Kempf T, et al.Circula-ting concentrations of follistatin-like 1 in healthy indivi-duals and patients with acute coronary syndrome as assessed by an immunoluminometric sandwich assay[J]. Clin Chem,2009,55(10):1794-1800. [29] Widera C, Giannitsis E, Kempf T, et al.Identification of follistatin-like 1 by expression cloning as an activator of the growth differentiation factor 15 gene and a prognostic biomarker in acute coronary syndrome[J]. Clin Chem,2012,58(8):1233-1241. [30] Sanchis-Gomar F, Perez-Quilis C, Lucia A.Overexpres-sing FSTL1 for Heart Repair[J]. Trends Mol Med,2016, 22(5):353-354. [31] Fujio Y, Nguyen T, Wencker D, et al.Akt promotes survival of cardiomyocytes [32] Yue TL, Wang C, Gu JL, et al.Inhibition of extracellular signal-regulated kinase enhances Ischemia/Reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart[J]. Circ Res,2000,86(6):692-699. [33] Squires CE, Escobar GP, Payne JF, et al.Altered fibroblast function following myocardial infarction[J]. J Mol Cell Cardiol,2005,39(4):699-707. [34] Takahashi M, Okubo N, Chosa N, et al.Fibroblast growth factor-1-induced ERK1/2 signaling reciprocally regulates proliferation and smooth muscle cell differentiation of ligament-derived endothelial progenitor cell-like cells[J]. Int J Mol Med,2012,29(3):357-364. [35] Sepe L, Ferrari MC, Cantarella C, et al.Ras activated ERK and PI3K pathways differentially affect directional movement of cultured fibroblasts[J]. Cell Physiol Biochem,2013,31(1):123-142. [36] Shaw AK, Pickup MW, Chytil A, et al.TGFβ signaling in myeloid cells regulates mammary carcinoma cell invasion through fibroblast interactions[J]. PLoS One,2015, 10(1):e0117908. [37] Tanaka K, Valero-Muñoz M, Wilson RM, et al.Follistatin like 1 Regulates Hypertrophy in Heart Failure with Preserved Ejection Fraction[J]. JACC Basic Transl Sci,2016, 1(4):207-221. [38] Ikeda Y, Sato K, Pimentel DR, et al.Cardiac-specific deletion of LKB1 leads to hypertrophy and dysfunction[J]. J Biol Chem,2009,284(51):35839-35849. [39] Zhang P, Hu X, Xu X, et al.AMP activated protein kinase-alpha2 deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction in mice[J]. Hypertension,2008,52(5):918-924. [40] Ouchi N, Kobayashi H, Kihara S, et al.Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells[J]. J Biol Chem,2004,279(2):1304-1309. [41] Kempf T, Wollert KC.Nitric oxide and the enigma of cardiac hypertrophy[J]. Bioessays,2004,26(6):608-615. [42] El-Armouche A, Ouchi N, Tanaka K, et al.Follistatin-like 1 in chronic systolic heart failure: a marker of left ventricular remodeling[J]. Circ Heart Fail,2011,4(5):621-627. [43] Kempf T1, Eden M, Strelau J, et al. The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury[J]. Circ Res,2006,98(3):351-360. [44] Wollert KC, Kempf T, Peter T, et al.Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome[J]. Circulation,2007, 115(8):962-971. |
| [1] | 桂燕萍, 陈晔芬, 施仲伟, 许燕.超声心动图右室面积变化分数筛查左心室射血分数降低的心力衰竭患者心脏同步性研究[J]. 诊断学理论与实践, 2022, 21(03): 331-335. |
| [2] | 盛虹, 章安迪.慢性心力衰竭住院患者营养风险评估的临床应用研究[J]. 诊断学理论与实践, 2021, 20(02): 178-183. |
| [3] | 张中文, 左祥荣, 郑绪辉, 曹权, 李新立, 李艳秀.3q26 rs12696304基因多态性与中国南方汉族老年人群急性心力衰竭患者一年预后间的关系研究[J]. 诊断学理论与实践, 2020, 19(06): 565-571. |
| [4] | 王春花, 祁爽, 王敏.原发性醛固酮增多症合并无痛性心肌梗死一例报告[J]. 诊断学理论与实践, 2020, 19(05): 528-530. |
| [5] | 罗晓颖, 许燕, 张建盛, 吴立群, 戚文航.N端脑钠肽前体预测首次急性心肌梗死后新发心房颤动的价值研究[J]. 诊断学理论与实践, 2020, 19(03): 303-307. |
| [6] | 周桑, 沈茜, 秦永文.肌钙蛋白I自身抗体在心肌梗死诊断中的临床意义[J]. 诊断学理论与实践, 2017, 16(01): 120-122. |
| [7] | 万颖蕾, 倪逸敏, 顾志冬.心型脂肪酸结合蛋白在急性心肌梗死患者早期诊断中的应用价值[J]. 诊断学理论与实践, 2016, 15(06): 582-585. |
| [8] | 桂燕萍, 施仲伟,.超声测量心外膜脂肪组织厚度在慢性心力衰竭患者中的临床价值[J]. 诊断学理论与实践, 2016, 15(03): 248-252. |
| [9] | 罗晓颖, 许燕, 张凤如, 张瑞岩, 戚文航,.血清铁蛋白与首次急性心肌梗死预后的关系[J]. 诊断学理论与实践, 2014, 13(06): 610-612. |
| [10] | 罗晓颖, 许燕, 施仲伟, 张凤如, 戚文航,.左心室射血分数正常的心力衰竭患者临床特点——单中心资料[J]. 诊断学理论与实践, 2012, 11(03): 258-262. |
| [11] | 钱泓洁, 汤正义,.糖尿病合并心力衰竭的发病与相关发病机制[J]. 诊断学理论与实践, 2012, 11(01): 84-87. |
| [12] | 卜玉莲, 张欢, 潘自来, 李剑颖, 杨文洁, 庞丽芳, 肖华, 陈克敏, 严福华,.能谱CT在梗死心肌诊断中的临床应用[J]. 诊断学理论与实践, 2011, 10(06): 517-522. |
| [13] | 陈怡琳, 施仲伟, 胡厚达, 许燕, 张凤如,.速度向量成像技术定量评价冠心病患者心肌扭转运动[J]. 诊断学理论与实践, 2011, 10(01): 26-29. |
| [14] | 刘艳, 金玮, 陆林, 陈秋静, 沈卫峰,.肿瘤坏死因子-α基因启动子区域多态与冠心病的相关性[J]. 诊断学理论与实践, 2009, 8(05): 506-509. |
| [15] | 田彩霞, 李艳, 邱方城, 秦维超, 郑卫东, 刘堂鑫,.CD40基因启动子区-1C/T多态性与早发急性心肌梗死的相关性研究[J]. 诊断学理论与实践, 2008, 7(05): 517-520. |
| 阅读次数 | ||||||
| 全文 |
|
|||||
| 摘要 |
|
|||||
